Latest News

Moderna’s work developing seasonal vaccines is ‘risky’ under current FDA, analyst says

February 11, 2026 at 03:44 PM
By MarketWatch
Moderna’s work developing seasonal vaccines is ‘risky’ under current FDA, analyst says

Advertisement Space - Below Article Title

The biotech company said the FDA won’t review its flu vaccine, in the latest hit to mRNA development.

Analysis & Context

The biotech company said the FDA won’t review its flu vaccine, in the latest hit to mRNA development. Moderna’s work developing seasonal vaccines is ‘risky’ under current FDA, analyst says. Stay informed with the latest developments and expert analysis on this important story.

Advertisement Space - In-Article Ad

The biotech company said the FDA won’t review its flu vaccine, in the latest hit to mRNA development.

Advertisement Space - End of Article

Related Articles